As our country continues to respond and recover from the COVID-19 pandemic, which has impacted HIV and hepatitis services, we know we have the science to end two other infectious diseases that have been impacting our country for decades: HIV and hepatitis C. While there still is no cure or vaccine for HIV, we have preventive tools along with treatments that suppress the virus, and together can bring the number of new infections down to a point that we can end HIV.
Letter on FY2022 HIV prevention funding for PrEP in community health centers
We urge Congress to capitalize on the expertise of the community health centers as part of the EHE initiative so that we can expand PrEP and PrEP-related services by increasing funding from the current $102 million to $152 million, as proposed by President Biden’s FY2022 budget.
Testimony for the Record House Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies (FY 2022)
On behalf of the HIV+Hepatitis Policy Institute, we respectfully submit this testimony in support of increased funding for domestic HIV and hepatitis programs in the FY 2022 Labor, HHS spending bill.
Comments on additional policy and regulatory revisions in response to the COVID-19 public health emergency
The HIV+Hepatitis Policy Institute, a national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious…
Comments on draft HIV national strategic plan for the United States: A roadmap for elimination 2021-2025
Thank you for the opportunity to provide comments on the draft HIV National Strategic Plan for the United States: A Roadmap for Elimination 2021-2025 (HIV Plan). The HIV+Hepatitis Policy Institute is a leading…